A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism.
Saved in:
| Title: | A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism. |
|---|---|
| Authors: | Gillett, Daniel1,2 (AUTHOR), Senanayake, Russell1 (AUTHOR), MacFarlane, James1 (AUTHOR), Bashari, Waiel1 (AUTHOR), Palma, August1 (AUTHOR), Hu, Lihua1 (AUTHOR), Harper, Ines2 (AUTHOR), Mendichovszky, Iosif A.2,3 (AUTHOR), Antoni, Gunnar4 (AUTHOR), Hellman, Per5 (AUTHOR), Sundin, Anders5 (AUTHOR), Hird, Matthew6 (AUTHOR), Boros, István7 (AUTHOR), Brown, Morris J.8 (AUTHOR), Cheow, Heok2 (AUTHOR), Aloj, Luigi2,3 (AUTHOR), Aigbirhio, Franklin1,6,7 (AUTHOR), Gurnell, Mark1 (AUTHOR) mg299@medschl.cam.ac.uk |
| Source: | Journal of Nuclear Medicine. Mar2025, Vol. 66 Issue 3, p434-440. 7p. |
| Database: | Engineering Source |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 01615505 |
|---|---|
| DOI: | 10.2967/jnumed.124.268425 |
